ARCHIVES

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Bush Tax Cut, Economic Slowdown Turn Up Heat On Budget Competition.

July 20, 2001

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

July 18, 1980